The role of combination therapy with antiplatelet and oral anticoagulant agents in cardiovascular disease

Research output: Contribution to journalReview article


This review examines the use of combinations of oral antiplatelet agents with oral anticoagulant agents for long-term secondary prevention in patients with cardiovascular diseases such as myocardial infarction (MI), mechanical valve replacement, coronary artery stent implantation, and chronic atrial fibrillation (AF).

Original languageEnglish
Pages (from-to)561-562+565
JournalP and T
Issue number11
Publication statusPublished - 2001


All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this